These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14333171)

  • 1. [CLEARING ACTION OF HEPARIN AND HEPARINOID SUBSTANCES IN THERAPY OF ARTERIOSCLEROSIS].
    MEONI G
    Clin Ter; 1965 Mar; 32():445-60. PubMed ID: 14333171
    [No Abstract]   [Full Text] [Related]  

  • 2. HEPARIN-LIKE SUBSTANCES AND ATHEROSCLEROSIS; A CLINICAL SURVEY AFTER FOUR YEARS OF THERAPEUTIC USE OF A DUODENAL HEPARINOID.
    COSTA U; AZZENA D; ASTENGO F; GHIGLIOTTI G
    G Gerontol; 1964 Feb; 12():201-2. PubMed ID: 14163031
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical aspects of the hypocholesterolemic and clearing action of a heparinoid and its relation to atherosclerosis].
    ALMAFARA ML; ORLANDO MM
    Sem Med; 1962 Mar; 120():433-6. PubMed ID: 13860649
    [No Abstract]   [Full Text] [Related]  

  • 4. [On oral treatment with heparin and heparinoids].
    HEYMANN W
    Bibl Haematol; 1963; 15():132-9. PubMed ID: 13954327
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the clearing action of 16 alpha-Chloroestrone-3-methyl ether and heparinoid substances].
    LEGNANI F; GIUDICI G
    Rass Giuliana Med; 1959 Aug; 15():235-7. PubMed ID: 14415324
    [No Abstract]   [Full Text] [Related]  

  • 6. FIRST RESULTS ON THE TREATMENT OF DISLIPEMIAS OBTAINED WITH THE USE OF A PANCREATIC HEPARIN-LIKE SUBSTANCE.
    AZZENA D; GHIGLIOTTI G; ASTENGO F; MOLINELLI G
    G Gerontol; 1964 Feb; 12():169-70. PubMed ID: 14163027
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE SIGNIFICANCE OF INSUFFICIENT CLEARANCE IN ATHEROGENESIS].
    SCHOEN H
    Munch Med Wochenschr; 1963 Dec; 105():2473-8. PubMed ID: 14133657
    [No Abstract]   [Full Text] [Related]  

  • 8. [Survey of lipid metabolism in 100 patients suspected of atherosclerosis. Therapeutic trial of a new synthetic heparinoid: CB 8061. (Apropos of 30 cases)].
    LEBLOIS J; LESAGE R; RIVET E
    Lille Med; 1962 Mar; 7():256-63. PubMed ID: 14463327
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACTION OF A DUODENAL HEPARINOID ON PLASMA LIPIDS AND SUGARS].
    BERRETA JA; CAMPAGNOLI M; SALITA S; LOFFLER AJ; ZUNDER J; PRESS L; BARBEITOARANDA A; KALINOV A
    Prensa Med Argent; 1964 Nov; 51():1267-71. PubMed ID: 14240198
    [No Abstract]   [Full Text] [Related]  

  • 10. Clearing system for blood fats; stimulation by a heparinoid.
    DUNCAN CH; BEST MM; McGAFF CJ
    Lancet; 1959 May; 1(7081):1014-6. PubMed ID: 13655659
    [No Abstract]   [Full Text] [Related]  

  • 11. [ACTION OF A SYNTHETIC HEPARINOID ON THE HUMORAL SYNDROME OF ATHEROSCLEROSIS].
    RAYNAUD R; BROCHIER ; TADEI
    Rev Atheroscler; 1963; 5():23-31. PubMed ID: 14121729
    [No Abstract]   [Full Text] [Related]  

  • 12. The blood heparinoid substances in human atherosclerosis.
    NIKKILA EA; MAJANEN S
    Scand J Clin Lab Invest; 1952; 4(3):204-10. PubMed ID: 13014993
    [No Abstract]   [Full Text] [Related]  

  • 13. [CLINICAL TRIALS OF A NEW SYNTHETIC HEPARINOID: CB-8,061].
    CHASSAGNON C; PERRIN A; MEY JP
    Lyon Med; 1963 Dec; 210():1125-41. PubMed ID: 14100236
    [No Abstract]   [Full Text] [Related]  

  • 14. [On influencing the physiological coagulation time and the clearing factor by total body inunction with alpha-heparin and heparinoid ointments].
    STUETTGEN G; BRUESTER H
    Dermatol Wochenschr; 1960 Jan; 141():97-102. PubMed ID: 13835417
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heparinogen. 2. On the mechanism of action of heparinoids].
    PULVER R
    Arzneimittelforschung; 1963 Jul; 13():581-4. PubMed ID: 13972519
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of the tetracyclines on heparin and heparinoid substances in the blood].
    BERNASCONI E; BERNASCONI P; CONFALONIERI C
    G Ital Chemioter; 1956; 3(1-2):79-84. PubMed ID: 13366003
    [No Abstract]   [Full Text] [Related]  

  • 17. [ACTION OF A HEPARINOID IN ARTERIOSCLEROTICS UNDER ANTICOAGULANT THROMBOLYTIC TREATMENT].
    MORELLI AC
    Sem Med; 1963 Dec; 123():1879-84. PubMed ID: 14168961
    [No Abstract]   [Full Text] [Related]  

  • 18. [USE OF A SYNTHETIC HEPARINOID IN LIPID METABOLISM DISORDERS. PRELIMINARY STUDY].
    RABY C; SAINT-BLANCARD J; PAGE G; BIED B; VIGNE J; OUGIER J
    Sem Ther; 1963 Dec; 39():658-64. PubMed ID: 14116089
    [No Abstract]   [Full Text] [Related]  

  • 19. [USE OF A SYNTHETIC HEPARINOID: CB 8061. CONSIDERATIONS ON 50 CASES AFTER 10 MONTHS OF CLINICAL AND BIOLOGICAL TRIALS].
    MANS J; GENES M
    J Med Bord; 1963 Dec; 140():1886-93. PubMed ID: 14099058
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the action of a synthetic heparinoid.
    SEIFTER J; BEGANY AJ
    Am J Med Sci; 1948 Aug; 216(2):234. PubMed ID: 18884743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.